Journals / Retina-Vitreus / 2021 / Cilt: 30 - Sayı: 2

Secondary Glaucoma After Intravitreal Dexamethasone Implant in The Patient with Macular Edema Secondary to Retinitis Pigmentosa

Pages
190–193
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies are needed to confirm the safety and efficacy of intravitreal Ozurdex® for macular edema in retinitis pigmentosa.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Macular edema can be occured in cases of retinitis pigmentosa.
📊
Key Findings & Data:One of the treatment agent for cystoid macular edema secondary t o retinitis pigmentosa is intravitreal Ozurdex implant.
💡
Conclusion & Impact:Further studies are needed to confirm the safety and efficacy of intravitreal Ozurdex® for macular edema in retinitis pigmentosa.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Macular edema can be occured in cases of retinitis pigmentosa. One of the treatment agent for cystoid macular edema secondary t o retinitis pigmentosa is intravitreal Ozurdex implant. Secondary glaucoma is one of the complication of intravitreal corticosteroid injection for macular edema. In this article the retinitis pigmantosa case with secondary glaucoma resistent to medical treatment after ozurdex implant for refractory macular edema is presented. To present a case with bilateral refractory macular edema secondary to retinitis pigmentosa improved glaucoma in one eye after one month following Ozurdex® (Allergan, Inc., Irvine, CA, USA) implantation. Further studies are needed to confirm the safety and efficacy of intravitreal Ozurdex® for macular edema in retinitis pigmentosa.

🔖

Cite This Article

ERTAN, E., MUTLU, M., DUMAN, R., DUMAN, R., YAVAŞ, G. F. (2022). Secondary Glaucoma After Intravitreal Dexamethasone Implant in The Patient with Macular Edema Secondary to Retinitis Pigmentosa. Retina-Vitreus, Cilt: 30 - Sayı: 2, 190–193. https://ajindex.com/articles/589050

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Harton DT, Berson EI, Dryja TP. Retinitis Pigmentosa. Lancet 2006;368:1795-1809
  2. Fishman GA, Glenn AM & Gilbert LD. Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 1993:111: 1640 -6
  3. Sahel J, Bonnel S, Mrejen S, Paques M.Retinitis pigmentosa and other dystrophies. Dev Ophthalmol 2010: 47:160-7
  4. Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol.1989 Oct; 107:1445-52
  5. Huckfeldt RM, Comander J. Management of Cystoid Macular Edema in Retinitis Pigmentosa. Semin Ophthalmol. 2017;32:43-51
  6. Haller JA, Bandello F, Belfort Jr R, et al. Randomized, sham- controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134
  7. Srour M, Querques G, Leveziel N, Zerbib J, Tilleul J, Boulanger- Scemama E, Souied EH. Intravitreal dexamethasone implant (Ozurdex) for macular edema secondary to retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2013;251:1501-6
  8. Ahn SJ, Kim KE, Woo SJ, Park KH. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review. Ophthalmic Surg Lasers Imaging Retina. 2014;45:160-4
  9. Saatci AO, Selver OB, Seymenoglu G, Yaman A. Bilateral intravitreal dexamethasone implant for retinitis pigmentosa- related macular edema. Case Rep Ophthalmol. 2013;4:53-8
  10. Kuppermann BD Blumenkranz MS Haller JA. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema. Arch Ophthalmol. 2007;125(3):309-317. 11.Örnek N, Örnek K, Erbahçeci İE.Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa. Turk J Ophthalmol. 2016 Aug;46(4):179-181.